Skip to content

News

News from OXGENE across Gene Therapy, Antibody and CRISPR.

Filter by:
Aldevron interview

Aldevron interview

Portfolio company Oxford Genetics, announces six licensing deals

Portfolio company Oxford Genetics, announces six licensing deals

Oxford Genetics collaborates to develop gene editing workflows

Oxford Genetics collaborates to develop gene editing workflows

Oxford Genetics announces the appointment of their new Chief Operating Officer, Jocelyne Bath

Oxford Genetics announces the appointment of their new Chief Operating Officer, Jocelyne Bath

Oxford Genetics Announces Licensing Deal of its Lentivirus Plasmids

Oxford Genetics Announces Licensing Deal of its Lentivirus Plasmids

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Oxford Genetics Announces New Online Customer Portal for Custom Research Services

Oxford Genetics Announces New Online Customer Portal for Custom Research Services

Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.

Login

Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.